Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice

@article{Wang2002GlucagonlikePT,
  title={Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice},
  author={Qidi Wang and Peter H. Brubaker},
  journal={Diabetologia},
  year={2002},
  volume={45},
  pages={1263-1273}
}
Aims/hypothesis. Glucagon-like peptide-1 ameliorates the symptoms of diabetes through stimulation of insulin secretion and enhancement of beta-cell mass. We have therefore investigated the effects of glucagon-like peptide-1 on the development of diabetes, using db/db mice as a model of Type II diabetes. Methods. The potent glucagon-like peptide-1 analogue Exendin-4 or vehicle (control) was administered (i.p.; 1 nmol/kg) to obese 6-week old db/db mice daily for 14 days (n=10). Results. By 8… CONTINUE READING
Highly Influential
This paper has highly influenced 13 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS

Citations

Publications citing this paper.
Showing 1-10 of 154 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 49 references

Integrative mitogenic role of protein kinase B/Akt in beta-cells.

Annals of the New York Academy of Sciences • 2000
View 4 Excerpts
Highly Influenced

Regu- lation of beta-cell mass by hormones and growth factors

JH Nielson, ED Galsgaard, A Moldrup
Diabetes 50:S25–S29 • 2001
View 1 Excerpt

Similar Papers

Loading similar papers…